RxDoctor Payments Data

Anand Singla, MD

Gastroenterology · Seattle, WANPI 1487965463

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $17,295 of the $24,710 with a category attached, or 70.0%. Boston Scientific accounts for 76.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $11,670 and has fallen 92.5% since, to $879 in 2025. Among gastroenterology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,710in general payments, 2019–2025

Across 95 payments — averaging $260.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$19K
  • Covidien LP$4K
  • Olympus Corporation Of The Americas$843
  • Novartis$444
  • Fujifilm Healthcare Americas Corporation$317
  • 3-d Matrix, Inc.$165
  • plus $388 from 6 others

What the payments were for

  • Speaking & faculty fees$17,29570%
  • Travel & lodging$3,31413%
  • Food & beverage$4,10217%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific48$18,924
Covidien LP5$3,630
Olympus Corporation Of The Americas7$843
Novartis25$444
Fujifilm Healthcare Americas Corporation2$317
3-d Matrix, Inc.1$165
Olympus America Inc.2$154
AbbVie1$123
Omega Medical Imaging, LLC1$49
ERBE USA Inc1$30
Creo Medical Inc.1$19
Apollo Endosurgery US Inc1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,710 in reported general payments places this provider in the 90th percentile of 447 gastroenterology providers in Washington.

See all gastroenterology providers in Washington

Medicare billing

Part B allowed, 2024
$90,856
Medicare patients
221
Services billed
532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MotegrityPrucalopride Succinate12$6,467
Omeprazole35$1,131
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl17$274
Famotidine13$271
Pantoprazole Sodium12$56
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$56

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →